Showing results (231-240 of 275) with videos related to

Sort By:
Pageof 28
Immunology|September 1, 1991
Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DRA Faith, C Moreno, R Lathigra, et al.
BMJ Supportive & Palliative Care|July 10, 2015
Preferred and actual place of death in haematological malignancyD A Howell, H I Wang, E Roman, et al.
Blood|February 27, 2001
Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adultsM T Smith, Y Wang, E Kane, et al.
Environmental Health Perspectives|June 15, 2000
Workshop to identify critical windows of exposure for children's health: cancer work group summaryA F Olshan, L Anderson, E Roman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2011
Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United KingdomT J Lightfoot, W T Johnston, J Simpson, et al.
British Journal of Cancer|February 22, 2002
Vitamin K and childhood cancer: analysis of individual patient data from six case-control studiesE Roman, N T Fear, P Ansell, et al.
American Journal of Epidemiology|December 22, 2006
Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer StudyE Roman, J Simpson, P Ansell, et al.
Journal of the American Society for Mass Spectrometry|April 9, 2021
High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute MonitoringJames R Arndt, Kelly L Wormwood Moser, Gregory Van Aken, et al.
Adicciones|December 18, 2020
Internet, video game and mobile phone addiction in children and adolescents diagnosed with ADHD: A case-control studyA Menéndez-García, A Jiménez-Arroyo, M Rodrigo-Yanguas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatmentF E Davies, S J Rollinson, A C Rawstron, et al.
Pageof 28